Departed
Ginna Laport
Chief Medical Officer
CARGO Therapeutics, Inc.
Dr. Ginna Laport, the Company’s Chief Medical Officer ("CMO"), will be leaving the Company effective May 19, 2025.
Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 3851–3900 of 33446
Dr. Ginna Laport, the Company’s Chief Medical Officer ("CMO"), will be leaving the Company effective May 19, 2025.
On March 12, 2025, Eric K. Brandt advised the Board of Directors (the “Board”) of The Macerich Company (the “Company”) that he will not stand for re-election as a director of the Company at the 2025 annual meeting of stockholders (the “2025 Annual Meeting”).
On March 12, 2025, Jaynie Studenmund, a member of the Board of Directors (the “Board”) of ExlService Holdings, Inc. (the “Company”), notified the Board that she has decided not to stand for re-election at the Company’s 2025 annual meeting of stockholders (the “Annual Meeting”), at which time she will resign from the Board and the committees on which she currently serves.
at the Effective Time, Vikas Sinha, Derek Adams, Ph.D., Malcom Brenner, M.D., Ph.D., Jeffrey S. Bornstein, Shawn Tomasello and Juan Vera, M.D., resigned from the Board
at the Effective Time, Vikas Sinha, Derek Adams, Ph.D., Malcom Brenner, M.D., Ph.D., Jeffrey S. Bornstein, Shawn Tomasello and Juan Vera, M.D., resigned from the Board
at the Effective Time, Vikas Sinha, Derek Adams, Ph.D., Malcom Brenner, M.D., Ph.D., Jeffrey S. Bornstein, Shawn Tomasello and Juan Vera, M.D., resigned from the Board
at the Effective Time, Vikas Sinha, Derek Adams, Ph.D., Malcom Brenner, M.D., Ph.D., Jeffrey S. Bornstein, Shawn Tomasello and Juan Vera, M.D., resigned from the Board
at the Effective Time, Vikas Sinha, Derek Adams, Ph.D., Malcom Brenner, M.D., Ph.D., Jeffrey S. Bornstein, Shawn Tomasello and Juan Vera, M.D., resigned from the Board
at the Effective Time, Vikas Sinha, Derek Adams, Ph.D., Malcom Brenner, M.D., Ph.D., Jeffrey S. Bornstein, Shawn Tomasello and Juan Vera, M.D., resigned from the Board
the resignation of Mr. P. Gregory Garrison from the Board on March 19, 2025
On March 17, 2025, Douglas L. Kieta, the Chairman of the Board of the Company notified the Company that he will not stand for re-election to the Board at the Company’s upcoming 2025 Annual Meeting to be held on June 25, 2025, and therefore his term as a director will end at the 2025 Annual Meeting.
On March 17, 2025, Michael D. Kandris, a member of the Board, notified the Company that he will not stand for re-election to the Board at the Company’s upcoming 2025 Annual Meeting, and therefore his term as a director will end at the 2025 Annual Meeting.
Mr. Kelvin (Zeng Yenn) Chin, the chief financial officer of Globalink Investment Inc., a company formed under the laws of Delaware (the “Company”), notified the Company of his resignation as the chief financial officer and a director of the Company, effective March 17, 2025.
On March 12, 2025, Eric Leupold notified Forge Global Holdings, Inc. (the “Company”) of his intention to resign from the Company’s Board of Directors (the “Board”), effective March 17, 2025.
On March 12, 2025, Kelly Galloway, Senior Vice President and Chief Accounting Officer of Hertz Global Holdings, Inc. (the “Company”) and The Hertz Corporation (“Hertz”), informed the Company of her intent to resign from her role with the Company and Hertz to accept a role outside the Company.
On March 18, 2025, director E. Warren Matthews notified the Board of Directors of Carter Bankshares, Inc. (the “Company”) that he will retire and not stand for re-election to the Board of Directors of the Company (the “Board”) at its 2025 Annual Meeting of Shareholders to be held on May 28, 2025 (the “Annual Meeting”).
removed the following members from Fannie Mae’s Board of Directors: • Amy E. Alving • Christopher J. Brummer • Michael J. Heid • Simon Johnson • Diane N. Lye • Diane C. Nordin • Chetlur S. Ragavan • Michael A. Seelig
removed the following members from Fannie Mae’s Board of Directors: • Amy E. Alving • Christopher J. Brummer • Michael J. Heid • Simon Johnson • Diane N. Lye • Diane C. Nordin • Chetlur S. Ragavan • Michael A. Seelig
removed the following members from Fannie Mae’s Board of Directors: • Amy E. Alving • Christopher J. Brummer • Michael J. Heid • Simon Johnson • Diane N. Lye • Diane C. Nordin • Chetlur S. Ragavan • Michael A. Seelig
removed the following members from Fannie Mae’s Board of Directors: • Amy E. Alving • Christopher J. Brummer • Michael J. Heid • Simon Johnson • Diane N. Lye • Diane C. Nordin • Chetlur S. Ragavan • Michael A. Seelig
removed the following members from Fannie Mae’s Board of Directors: • Amy E. Alving • Christopher J. Brummer • Michael J. Heid • Simon Johnson • Diane N. Lye • Diane C. Nordin • Chetlur S. Ragavan • Michael A. Seelig
removed the following members from Fannie Mae’s Board of Directors: • Amy E. Alving • Christopher J. Brummer • Michael J. Heid • Simon Johnson • Diane N. Lye • Diane C. Nordin • Chetlur S. Ragavan • Michael A. Seelig
removed the following members from Fannie Mae’s Board of Directors: • Amy E. Alving • Christopher J. Brummer • Michael J. Heid • Simon Johnson • Diane N. Lye • Diane C. Nordin • Chetlur S. Ragavan • Michael A. Seelig
removed the following members from Fannie Mae’s Board of Directors: • Amy E. Alving • Christopher J. Brummer • Michael J. Heid • Simon Johnson • Diane N. Lye • Diane C. Nordin • Chetlur S. Ragavan • Michael A. Seelig
Brian W. Bolster, Executive Vice President, Finance and Chief Financial Officer of NEE and Florida Power & Light Company (FPL), resigned from those positions effective May 22, 2025 and was appointed President and Chief Executive Officer of NEER to succeed Ms. Kujawa effective May 22, 2025.
Rebecca Kujawa, President and Chief Executive Officer of NextEra Energy Resources, LLC (NEER), a subsidiary of NextEra Energy, Inc. (NEE), notified NEE that she plans to retire from those positions effective May 22, 2025 as part of a planned leadership succession process.
Philippe Lemaitre, the Chair of the Company’s Board of Directors (the “Board”) notified the Company of his decision to retire and not seek re-nomination at the 2025 Annual Meeting.
Effective March 10, 2025, the service of John A. Scarlett, M.D. as the President, Chief Executive Officer and Chairman of the Board of Directors (the “Board”) of Geron Corporation (the “Company” or “Geron”) concluded and, in connection therewith, Dr. Scarlett resigned from the Board.
Carl N. Scibetta, the Company’s Senior Executive Vice President, Chief Merchandising Officer, also will not participate in the Executive Incentive Compensation Plan in fiscal 2025 in light of his retirement from the Company in April 2025.
On March 17, 2025, the Company announced that Scott Bowman, Chief Financial Officer and Treasurer (and, in such capacities, principal financial officer and principal accounting officer) of the Company, departed from the Company, effective March 14, 2025.
On March 12, 2025, Timothy McFadden, a director of Kingstone Companies, Inc. (the “Company”), informed the Board of Directors of the Company (the “Board”) that he will not be seeking re-election to the Board at the 2025 annual meeting of stockholders.
On March 16, 2025, Sunit Patel, a non-employee director of Crown Castle Inc. ("Company"), notified the Company of his decision to resign from his position as a director on the Company's Board of Directors ("Board"), effective March 17, 2025.
Anthony F. Markel informed the Company on March 14, 2025 that he will not stand for re-election as a director at the Company's 2025 Annual Meeting of Shareholders scheduled to be held May 21, 2025. Mr. Markel will retire as a director of the Company at the end of the meeting.
On March 14, 2025, Jeremy A. Noble, President, Insurance, and the Company mutually agreed on a departure date of April 13, 2025.
On March 11, 2025, Walter Jackson notified the Board of Trustees (the “ Board ”) of the Antares Private Credit Fund (the “ Company ”) that he is resigning from the Board of the Company effective immediately.
On March 11, 2025, Walter Jackson notified the Board of Trustees (the “ Board ”) of the Antares Strategic Credit Fund (the “ Company ”) that he is resigning from the Board of the Company effective immediately.
Gwen Melincoff also advised the Board that she will not stand for re-election at the Annual Meeting and will retire from the Board at that time.
Michael Heffernan, R.Ph., founder and current Chairman of the Board advised the Board that he will not stand for re-election at the Annual Meeting and will retire from the Board at that time.
On March 14, 2025, Jonathan Seiffer resigned from the board of directors of the Company effective immediately.
Edward T. Gallivan, Jr. notified the board of directors of the Company (the “Board”) of his resignation as chief financial officer of the Company, effective April 1, 2025.
On March 11, 2025, John Dahldorf, the Chief Financial Officer of Adagio Medical Holdings, Inc. (the “Company”) announced his decision to resign as Chief Financial Officer, effective March 21, 2025.
On March 11, 2025, Chukwuemeka (Emeka) A. Oyolu, Senior Vice President, Chief Accounting Officer, and principal accounting officer of LyondellBasell Industries N.V. (the “Company”), informed the Company of his intent to resign, effective as of March 24, 2025, to pursue another opportunity.
the Company announced certain changes to its Board of Directors, including the decision by William F. Doyle to resign from the Board, effective upon the Company entering into a research agreement
On March 17, 2025, the Board of Directors (the “Board”) of Ryman Hospitality Properties, Inc. (the “Company”) accepted the resignation of Fazal F. Merchant as a member of the Board and as a member of the Audit Committee of the Board and of the Risk Committee of the Board, effective immediately.
By correspondence dated March 13, 2025, John Engel informed the Board of Directors (the “Board”) of Runway Growth Finance Corp., a Maryland corporation (the “Company”), of his intent to resign as a director of the Company, effective March 21, 2025
The employment of Brian C. Stephenson, the Chief Financial Officer of BridgeBio Pharma, Inc. (the “Company”), ended on March 17, 2025 (the “Effective Date”).
Mark Field, Senior Vice President, Chief Technology Officer of Insulet Corporation (the “ Company ”) left the Company to pursue other opportunities, effective March 14, 2025.
On March 12, 2025, Tejon Ranch Co. ("Company") Director Rhea Frawn Morgan informed the Company that she will not stand for reelection as a director at the 2025 annual meeting
Susan Bonner will depart from the position of Chief Commercial Officer, effective immediately.
David Desharnais, Chief Executive Officer of the Company, resigned from the Company, which resignation was accepted by Company’s Board of Directors on March 14, 2025.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.